Abstract 4461: Poor predictive power of BIM deletion polymorphism for EGFR tyrosine kinase inhibitor outcome in non-small cell lung cancer patients harboring EGFR mutation.

Mapping Intimacies ◽

10.1158/1538-7445.am2013-4461 ◽

2013 ◽

Author(s):

June Koo Lee ◽

Jong-Yeon Shin ◽

Soyeon Kim ◽

Sunhwa Lee ◽

Changho Park ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Predictive Power ◽

Egfr Mutation ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Deletion Polymorphism ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients

Download Full-text

RECIST progression patterns during EGFR tyrosine kinase inhibitor treatment of advanced non-small cell lung cancer patients harboring an EGFR mutation

Lung Cancer ◽

10.1016/j.lungcan.2015.09.025 ◽

2015 ◽

Vol 90 (3) ◽

pp. 477-483 ◽

Author(s):

Tatsuya Yoshida ◽

Kiyotaka Yoh ◽

Seiji Niho ◽

Shigeki Umemura ◽

Shingo Matsumoto ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Egfr Mutation ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients ◽

Inhibitor Treatment

Download Full-text

Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis

10.1186/1471-2407-11-1 ◽

2011 ◽

Vol 11 (1) ◽

Author(s):

Satoshi Watanabe ◽

Junta Tanaka ◽

Takeshi Ota ◽

Rie Kondo ◽

Hiroshi Tanaka ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients ◽

Clinical Responses

Download Full-text

9087 POSTER Clinical Responses to EGFR-tyrosine Kinase Inhibitor Retreatment in Non-small Cell Lung Cancer Patients Who Benefited Prior Gefitinib Therapy

European Journal of Cancer ◽

10.1016/s0959-8049(11)72399-1 ◽

2011 ◽

Vol 47 ◽

pp. S618-S619

Author(s):

S. Watanabe ◽

Y. Saida ◽

K. Ichikawa ◽

J. Koshio ◽

J. Baba ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients ◽

Clinical Responses

Download Full-text

Pneumonitis in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitor: Meta-analysis of 153 cohorts with 15,713 patients

Lung Cancer ◽

10.1016/j.lungcan.2018.06.032 ◽

2018 ◽

Vol 123 ◽

pp. 60-69 ◽

Author(s):

Chong Hyun Suh ◽

Hye Sun Park ◽

Kyung Won Kim ◽

Junhee Pyo ◽

Hiroto Hatabu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Meta Analysis ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients

Download Full-text

Reply to the comments on: Pneumonitis in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitor: Meta-analysis of 153 cohorts with 15,713 patients: Meta-analysis of incidence and risk factors of EGFR-TKI pneumonitis in NSCLC

Lung Cancer ◽

10.1016/j.lungcan.2018.11.005 ◽

2019 ◽

Vol 127 ◽

pp. 168

Author(s):

Chong Hyun Suh ◽

Kyung Won Kim ◽

Mizuki Nishino

Keyword(s):

Risk Factors ◽

Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Meta Analysis ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients ◽

Download Full-text

Proposal of new CT response criteria in non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitor.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7035 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7035-7035

Author(s):

H. Lee ◽

K. Lee ◽

M. Ahn ◽

H. Hwang ◽

J. Lee ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients

Download Full-text

Predictive efficacy of11C-PD153035 PET imaging for EGFR-tyrosine kinase inhibitor sensitivity in non-small cell lung cancer patients

International Journal of Cancer ◽

10.1002/ijc.29832 ◽

2015 ◽

Vol 138 (4) ◽

pp. 1003-1012 ◽

Author(s):

Dong Dai ◽

Xiao-Feng Li ◽

Jian Wang ◽

Jian-Jing Liu ◽

Yan-Jia Zhu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Pet Imaging ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients

Download Full-text

Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-17-2310 ◽

2018 ◽

Vol 24 (13) ◽

pp. 3097-3107 ◽

Author(s):

Zhe Yang ◽

Nong Yang ◽

Qiuxiang Ou ◽

Yi Xiang ◽

Tao Jiang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Resistance Mechanisms ◽

Third Generation ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients

Download Full-text

Readministration of EGFR Tyrosine Kinase Inhibitor in Non-small Cell Lung Cancer Patients after Initial Failure, What Affects its Efficacy?

Scientific Reports ◽

10.1038/srep05996 ◽

2014 ◽

Vol 4 (1) ◽

Author(s):

Ze-Rui Zhao ◽

Wei li ◽

Hao Long

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients

Download Full-text

Continuous EGFR tyrosine kinase inhibitor treatment with or without chemotherapy beyond gradual progression in non-small cell lung cancer patients

OncoTargets and Therapy ◽

10.2147/ott.s143569 ◽

2017 ◽

Vol Volume 10 ◽

pp. 4261-4267 ◽

Author(s):

Ling Peng ◽

Yina Wang ◽

Yemin Tang ◽

Lei Zeng ◽

Junfang Liu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor ◽

Lung Cancer Patients ◽

Inhibitor Treatment

Download Full-text